Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AUREOMYCIN 50G PREMIX DIN 02230723

Status: Cancelled Post Market
Holder: HOFFMANN-LA ROCHE LIMITED
Molecule: CHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM)

Health Canada record

Active ingredient(s)CHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM) 110 G
Dosage formDrug Premix
RouteOral
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date11-Nov-1997
Current status date27-Jul-2000
SourceHealth Canada DPD

Establishment licence of the holder

Hoffmann-La Roche Limited — licence 100006, currently licensed, last inspection rating C (2024-06-25).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM)

DINProductCompanyFormStrengthStatus
02230724AUREOMYCIN 100G PREMIXHOFFMANN-LA ROCHE LIMITEDDrug PremixCHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM) 220 GCancelled Post Market
02242817AUREOMYCIN 110 GZOETIS CANADA INCDrug PremixCHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM) 110 GCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
64201997-02-27New Drug Submission (NDS)
Request a quote for AUREOMYCIN 50G PREMIX

How to read a Canadian DIN record